{
    "2020-06-05": [
        [
            {
                "time": "2020-06-05",
                "original_text": "Pharma Giant AbbVie Enters Ring With A Potential Coronavirus Treatment",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Coronavirus",
                        "Treatment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "AbbVie Enters the Race to Develop New COVID-19 Treatments",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Race",
                        "COVID-19",
                        "Treatments"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "Biotech Stock To Watch: Why This Leader Could Be Poised For Another Run",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stock",
                        "Leader",
                        "Run"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "The Market Timing Secrets No One Talks About - June 05, 2020",
                "features": {
                    "keywords": [
                        "Market",
                        "Timing",
                        "Secrets"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "The Zacks Analyst Blog Highlights: AbbVie, Amkor Technology, Calix, The Hain Celestial Group and Acacia Communications",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "AbbVie",
                        "Amkor",
                        "Technology",
                        "Calix",
                        "Hain",
                        "Celestial",
                        "Group",
                        "Acacia",
                        "Communications"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "communications"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "LLY",
                        "Coronavirus",
                        "Antibody",
                        "Phase",
                        "I",
                        "Study",
                        "FDA",
                        "Approvals"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid",
                "features": {
                    "keywords": [
                        "Daily",
                        "Biotech",
                        "Pulse",
                        "Adamas",
                        "Rallies",
                        "FDA",
                        "Acceptance",
                        "Oxford",
                        "Immunotech",
                        "Bid"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Harbour",
                        "BioMed",
                        "Utrecht",
                        "University",
                        "Erasmus",
                        "Medical",
                        "Center",
                        "Collaboration",
                        "Monoclonal",
                        "Antibody",
                        "Therapy",
                        "Prevent",
                        "Treat",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}